Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

Anaplastic Large Cell Lymphoma: combination therapy recommended to prevent treatment resistance ... of researchers led by molecular biologist Suzanne Turner from the University of Cambridge/Masaryk University Brno (CZ) and involving molecular pathologist Lukas Kenner from the MedUni Vienna, has now discovered a specific defence mechanism against certain drugs (ALK inhibitors), which promotes cancer... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-juli-2020/anaplastic-large-cell-lymphoma-combination-therapy-recommended-to-prevent-treatment-resistance/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=d6a47b90c57be0ce7173b71a5419b42e
Anaplastic Large Cell Lymphoma: combination therapy recommended to prevent treatment resistance ... of researchers led by molecular biologist Suzanne Turner from the University of Cambridge/Masaryk University Brno (CZ) and involving molecular pathologist Lukas Kenner from the MedUni Vienna, has now discovered a specific defence mechanism against certain drugs (ALK inhibitors), which promotes cancer... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-juli-2020/anaplastic-large-cell-lymphoma-combination-therapy-recommended-to-prevent-treatment-resistance/medicine-science/?L=3
Anaplastic Large Cell Lymphoma: combination therapy recommended to prevent treatment resistance ... of researchers led by molecular biologist Suzanne Turner from the University of Cambridge/Masaryk University Brno (CZ) and involving molecular pathologist Lukas Kenner from the MedUni Vienna, has now discovered a specific defence mechanism against certain drugs (ALK inhibitors), which promotes cancer... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-juli-2020/anaplastic-large-cell-lymphoma-combination-therapy-recommended-to-prevent-treatment-resistance/?L=3
Anaplastic Large Cell Lymphoma: combination therapy recommended to prevent treatment resistance ... of researchers led by molecular biologist Suzanne Turner from the University of Cambridge/Masaryk University Brno (CZ) and involving molecular pathologist Lukas Kenner from the MedUni Vienna, has now discovered a specific defence mechanism against certain drugs (ALK inhibitors), which promotes cancer... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-juli-2020/anaplastic-large-cell-lymphoma-combination-therapy-recommended-to-prevent-treatment-resistance/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=c3df047006f49bd9ace015bac8e08353
News ... mit einer geringeren Überlebenswahrscheinlichkeit von Brustkrebspatientinnen verbunden. "Unsere Ergebnisse legen nahe, dass die Ret-Enzyme (Ret-Kinase) eine attraktives und neuartiges therapeutisches Ziel in ausgewählten Gruppen von Brustkrebspatientinnen sein kann", fasst Lukas Kenner vom klinischen... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/neuer-ansatz-fuer-die-behandlung-von-brustkrebs/?L=3
News ... mit einer geringeren Überlebenswahrscheinlichkeit von Brustkrebspatientinnen verbunden. "Unsere Ergebnisse legen nahe, dass die Ret-Enzyme (Ret-Kinase) eine attraktives und neuartiges therapeutisches Ziel in ausgewählten Gruppen von Brustkrebspatientinnen sein kann", fasst Lukas Kenner vom klinischen... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=1504&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=511bbddda2ee5b88b1950a226ae90a9f
News ... mit einer geringeren Überlebenswahrscheinlichkeit von Brustkrebspatientinnen verbunden. "Unsere Ergebnisse legen nahe, dass die Ret-Enzyme (Ret-Kinase) eine attraktives und neuartiges therapeutisches Ziel in ausgewählten Gruppen von Brustkrebspatientinnen sein kann", fasst Lukas Kenner vom klinischen... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/?tx_news_pi1%5Bnews%5D=1504&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=511bbddda2ee5b88b1950a226ae90a9f
Detailsite | MedUni Vienna ... founded by Lukas Kenner (MedUni Vienna), the Salzburg scientist Olaf Merkel as well as Suzanne Turner (Cambridge / Great Britain). Only last year Kenner and Merkel discovered possible causes for lymph node cancer. They published their findings last year in the US science journal “PNAS”.“For lymphomas there is typically the pathological matching of chromosomes, which combines genes, which are otherwise not joined together, into a hybrid protein molecule”, according to Kenner. These molecules lead to severe activation in the tumours of the regulatory gene ALK, which normally transmits growth signals... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=621&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=5d784559dd7f93926502ff3e158e64ee
Detailsite | MedUni Vienna ... founded by Lukas Kenner (MedUni Vienna), the Salzburg scientist Olaf Merkel as well as Suzanne Turner (Cambridge / Great Britain). Only last year Kenner and Merkel discovered possible causes for lymph node cancer. They published their findings last year in the US science journal “PNAS”.“For lymphomas there is typically the pathological matching of chromosomes, which combines genes, which are otherwise not joined together, into a hybrid protein molecule”, according to Kenner. These molecules lead to severe activation in the tumours of the regulatory gene ALK, which normally transmits growth signals... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=5d784559dd7f93926502ff3e158e64ee&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=621
Detailsite | MedUni Vienna ... by Lukas Kenner (MedUni Vienna), the Salzburg scientist Olaf Merkel as well as Suzanne Turner (Cambridge / Great Britain). Only last year Kenner and Merkel discovered possible causes for lymph node cancer. They published their findings last year in the US science journal “PNAS”.“For lymphomas there is typically the pathological matching of chromosomes, which combines genes, which are otherwise not joined together, into a hybrid protein molecule”, according to Kenner. These molecules lead to severe activation in the tumours of the regulatory gene ALK, which normally transmits growth signals... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/scientists-discussed-new-treatment-approaches-in-lymph-node-cancer/?L=3